Почетна › Alopecija areata › Merilend
Kliničke studije za Alopecija areata u državi Merilend
5 studija za Alopecija areata traži učesnike na lokacijama u državi Merilend.
Zvanični tekst studije (na engleskom)
Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
- National Institutes of Health Clinical Center, Bethesda
Тражи се учесникФаза 2Здраве особе су добродошле
Узраст од 12 до 75 · Оба пола · Ажурирано 6. 11. 2026. · NCT05398809A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Cutaneous Translational Research Program, Johns Hopkins University School of Medicine, Baltimore
- Johns Hopkins Hospital Investigational Drug Services (IDS) Pharmacy, Baltimore
Тражи се учесникФаза 3
Узраст 12 и старији · Оба пола · Ажурирано 26. 10. 2026. · NCT07733765A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Johns Hopkins University, Baltimore
- Dermatology and Skin Cancer Specialists, LLC, Rockville
Тражи се учесникФаза 3
Узраст 12 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT06873945A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- Kindred Hair and Skin Center, Marriottsville
Тражи се учесникФаза 3
Узраст од 6 до 14 · Оба пола · Ажурирано 15. 10. 2026. · NCT07029828Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- U.S. Dermatology Partners - Rockville, Rockville
Тражи се учесникФаза 3
Узраст од 12 до 17 · Оба пола · Ажурирано 28. 1. 2026. · NCT07133308Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.